Hexagon shaped overlay

CAS Solutions

Designed to meet the needs of research, patent, regulatory, and business professionals in every phase of the innovation journey, CAS Solutions curate, connect, and analyze scientific knowledge to reveal unseen insights and relationships that accelerate your breakthroughs.

Contact us
solutions umbrella

CAS SciFinder Discovery Platform™

Serving the research process end-to-end

Get discoveries to market faster and optimize margins. By giving researchers the tools and information they need, you can avoid surprises, uncover competitive intelligence, and make smart investments.

STN IP Protection Suite™

Connecting R&D and intellectual property

Save time and money with intellectual property (IP) insights. From new users to expert searchers, the STN IP Protection Suite helps mitigate risks and respond faster to opportunities critical to your innovation journey.

CAS BioFinder Discovery Platform™

Simplify the drug discovery process

Accelerate your path to novel therapies with rapid, dependable insights into drug discovery data with predictive models. Dive into structure, target, and bioactivity details to confidently and quickly identify drug candidate molecules and potential drug targets.

CAS Custom Services℠

Accelerating breakthroughs with custom data, analytics, and insight

Partner directly with expert scientists and technologists at CAS to design custom solutions that leverage our content, technology, and expertise in new ways to drive efficiency innovation, capture emerging opportunities, and solve unique R&D and business challenges.

Other Solutions

Mitigating risk through guidance

Drive insights that inform your scientific workflows. CAS is the specialist in scientific information, providing focused solutions for regulatory compliance, supplier information, and chemical safety.

Latest from CAS Insights™

Emerging Science
Experts from CAS, Harvard Medical School, Procter & Gamble, and Cedars-Sinai Medical Center discuss health aging research.
|Article
Drug Discovery
PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
|Article
Digital R&D
Discover how artificial intelligence in pharma can enhance drug repurposing by leveraging dark data, ensuring data diversity, and improving data quality.
|Article